Peptide library.

NNMT inhibitor. Fat metabolism and muscle research.

Dose

50–150 mg

Freq

Daily (oral)

t½

~8 h

Vial

n/a

Route

Oral

Store

Room temp; dry

Soluble activin receptor (myostatin trap). Trials halted over vascular side effects. Experimental only.

Dose

Research only

Freq

n/a

t½

~10–15 days

Vial

1 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 21 days

Weak acid diluent used to dissolve poorly soluble peptides (e.g. some GLP-1s, MOTS-c) before adding BAC water.

Dose

0.2–0.5 mL then dilute

Freq

As needed

t½

n/a

Vial

n/a

Route

Diluent

Store

Room temp

Investigational adipose-targeted peptide. Preclinical only.

Dose

0.5 mg / kg

Freq

Daily cycle

t½

unknown

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Copper tripeptide studied for hair follicle growth and dermal collagen — a hair-focused counterpart to GHK-Cu.

Dose

1–3 mg (or topical)

Freq

Daily

t½

~2 h

Vial

50 mg

Route

Topical / subcutaneous

Store

Refrigerate reconstituted; 30 days

AMPK activator investigated as an exercise mimetic for glucose uptake and endurance.

Dose

10–50 mg

Freq

Daily

t½

~1 h

Vial

50 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Modified GH fragment (176-191) studied for fat metabolism without IGF-1 stimulation.

Dose

250–500 mcg

Freq

Daily

t½

~30 min

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

EPO-derived 11-mer targeting the innate repair receptor. Studied for small-fiber neuropathy and sarcoidosis pain.

Dose

2–4 mg

Freq

Daily × 28 days

t½

~2 min (long tissue effect)

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Injectable cobalamin for energy, methylation, and deficiency correction. Usually supplied as 1 mg/mL solution.

Dose

1 mg (1 mL)

Freq

1–2×/week

t½

~6 days

Vial

10 mg

Route

Intramuscular / subcutaneous

Store

Refrigerate; protect from light

Single-chain relaxin analog investigated for anti-fibrotic and cardiac remodeling effects.

Dose

100–300 mcg

Freq

Daily

t½

~2 h

Vial

2 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

0.9% benzyl-alcohol sterile water — the standard diluent for reconstituting lyophilized peptides.

Dose

1–5 mL per vial

Freq

As needed

t½

n/a

Vial

n/a

Route

Diluent

Store

Room temp; 28 days after first puncture

Neuromuscular blocker dosed in units by licensed injectors only. Not a research-peptide use case.

Dose

Clinical only (IU)

Freq

Every 3–4 months

t½

n/a

Vial

n/a

Route

Intramuscular (clinical)

Store

Refrigerate; reconstitute with saline

Body Protection Compound. Studied for GI, tendon, ligament, and soft-tissue repair.

Dose

200–500 mcg

Freq

1–2×/day

t½

~4 h (SC)

Vial

5 mg

Route

Subcutaneous / intramuscular near injury

Store

Refrigerate reconstituted; 28 days

Often stacked with TB-500 for injury recovery.

Classic recovery blend in equal ratio (e.g. 5 mg + 5 mg per vial) for soft tissue and tendon repair research.

Dose

500 mcg BPC + 500 mcg TB

Freq

1–2×/day

t½

mixed

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Total vial mg = both peptides combined; a 10 mg vial is 5 mg of each.

Bronchial tissue bioregulator studied for respiratory tissue function.

Dose

1–10 mg

Freq

Daily × 10–20 days

t½

short

Vial

20 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Long-acting amylin analog studied for appetite suppression and satiety; frequently paired with semaglutide.

Dose

0.3–2.4 mg

Freq

Weekly

t½

~7 days

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Amylin + GLP-1 combination studied for greater weight reduction than either alone. Titrate slowly.

Dose

0.3–2.4 mg of each

Freq

Weekly

t½

~7 days

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Cardiac tissue bioregulator researched for myocardial function and vascular health.

Dose

1–10 mg

Freq

Daily × 10–20 days

t½

short

Vial

20 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Cartilage and connective-tissue bioregulator; joint and bone research.

Dose

1–10 mg

Freq

Daily × 10–20 days

t½

short

Vial

20 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Porcine brain-derived peptide mixture studied for stroke recovery and dementia. Supplied as solution.

Dose

5–30 mg (1–5 mL)

Freq

Daily × 10–20 days

t½

short

Vial

60 mg

Route

Intramuscular / IV

Store

Refrigerate; use as supplied

GHRH analog. Short-acting pulse; pair with a GHRP like Ipamorelin.

Dose

100 mcg

Freq

1–3×/day

t½

~30 min

Vial

2 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 21 days

Standard GHRH + GHRP stack in one vial for synergistic GH pulse research.

Dose

100 mcg CJC + 200 mcg Ipa

Freq

Nightly

t½

mixed

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Long-acting GHRH via drug-affinity complex. Sustained GH baseline elevation.

Dose

1–2 mg

Freq

1–2×/week

t½

~8 days

Vial

2 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 21 days

Cerebral cortex bioregulator studied for peripheral nerve regeneration and cognition.

Dose

1–10 mg

Freq

Daily × 10–20 days

t½

short

Vial

20 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Immune-system bioregulator researched for thymic and lymphoid support.

Dose

1–10 mg

Freq

Daily × 10–20 days

t½

short

Vial

20 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Extremely potent opioid heptapeptide from frog skin. Analgesia research only — high risk, not for human use.

Dose

Research only

Freq

n/a

t½

~1 h

Vial

2 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Delta Sleep Inducing Peptide. Sleep architecture research.

Dose

100–500 mcg

Freq

Before sleep

t½

~7 min

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

GLP-1 receptor agonist fused to an Fc fragment for weekly dosing. Glycemic control research.

Dose

0.75–4.5 mg

Freq

Weekly

t½

~5 days

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Tetrapeptide investigated for telomerase activation and circadian rhythm.

Dose

5–10 mg

Freq

Daily × 10–20 days

t½

unknown

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Erythropoiesis-stimulating hormone dosed in IU. Serious thrombotic risk; medical supervision only.

Dose

Clinical only

Freq

n/a

t½

~4–13 h

Vial

n/a

Route

Subcutaneous

Store

Refrigerate; do not freeze

Senolytic peptide that disrupts FOXO4–p53 binding to clear senescent cells. Preclinical only.

Dose

Research only

Freq

Cycled

t½

unknown

Vial

2 mg

Route

Subcutaneous / IV

Store

Refrigerate reconstituted; 21 days

Copper tripeptide. Skin regeneration, hair, and wound healing research.

Dose

1–3 mg

Freq

Daily

t½

~2 h

Vial

50 mg

Route

Subcutaneous / topical

Store

Refrigerate reconstituted; 30 days

GH releasing peptide, less selective than Ipamorelin.

Dose

100–200 mcg

Freq

1–3×/day

t½

~15–60 min

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

GH releasing peptide, stimulates hunger via ghrelin pathway.

Dose

100–200 mcg

Freq

1–3×/day

t½

~15–60 min

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Skin-and-recovery blend: BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg per 70 mg vial.

Dose

~1/10 vial per dose

Freq

Daily

t½

mixed

Vial

70 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Master antioxidant tripeptide used for oxidative-stress support and skin brightening.

Dose

200–1200 mg

Freq

1–3×/week

t½

~10 min

Vial

600 mg

Route

Subcutaneous / IV / IM

Store

Refrigerate reconstituted; 30 days

GnRH analog. Fertility and HPTA research; often paired with TRT.

Dose

100–300 mcg

Freq

2–3×/week

t½

~10 min

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Human chorionic gonadotropin. LH-mimetic used for testicular function and fertility support. Dosed in IU.

Dose

250–1500 IU

Freq

2–3×/week

t½

~24–36 h

Vial

n/a

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Potent GHRP. Desensitization risk at higher doses.

Dose

100 mcg

Freq

1–3×/day

t½

~55 min

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Recombinant growth hormone, dosed in IU (≈3 IU per mg). Use an IU-based calculation, not mg.

Dose

1–4 IU

Freq

Daily

t½

~3–4 h

Vial

n/a

Route

Subcutaneous

Store

Refrigerate reconstituted; 14–21 days

C-terminal GH fragment researched for fat metabolism without affecting blood glucose or IGF-1.

Dose

250–500 mcg

Freq

1–2×/day

t½

~30 min

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

FSH/LH-containing gonadotropin used in fertility protocols. Dosed in IU.

Dose

75–150 IU

Freq

2–3×/week

t½

~short

Vial

n/a

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Mitochondrial-derived peptide studied for cytoprotection, insulin sensitivity, and neuroprotection.

Dose

1–5 mg

Freq

2–3×/week

t½

unknown

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Truncated IGF-1 variant with rapid, localized action at the injection site.

Dose

20–50 mcg

Freq

Pre-workout

t½

~20–30 min

Vial

2 mg

Route

Subcutaneous / IM

Store

Refrigerate reconstituted; 21 days

Long-acting IGF-1 analog researched for muscle hyperplasia and nutrient partitioning. Hypoglycemia risk.

Dose

20–50 mcg

Freq

Daily

t½

~20–30 h

Vial

1 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 21 days

Selective GHRP with minimal cortisol/prolactin impact. Often paired with CJC-1295.

Dose

200–300 mcg

Freq

1–3×/day

t½

~2 h

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Upstream regulator of GnRH. Reproductive endocrinology research.

Dose

100–200 mcg

Freq

Weekly

t½

~4 min

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

GLOW plus KPV 10 mg for added anti-inflammatory action. 80 mg total per vial.

Dose

~1/10 vial per dose

Freq

Daily

t½

mixed

Vial

80 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

α-MSH tripeptide fragment studied for anti-inflammatory action.

Dose

200–500 mcg

Freq

1–2×/day

t½

~2 h

Vial

5 mg

Route

Subcutaneous / oral

Store

Refrigerate reconstituted; 30 days

Amino acid derivative that shuttles fatty acids into mitochondria; endurance and fat-oxidation research.

Dose

200–600 mg

Freq

Daily pre-workout

t½

~4–15 h

Vial

600 mg

Route

Intramuscular / subcutaneous

Store

Refrigerate; solution

Tight junction modulator investigated for celiac and gut permeability.

Dose

0.25–0.5 mg

Freq

Before meals (oral)

t½

~1 h

Vial

n/a

Route

Oral

Store

Refrigerate

Pre-mixed lipolytic solution (bromelain, riboflavin, botanicals) marketed for localized fat dissolving. Supplied ready-to-use.

Dose

Per-area, clinical

Freq

Every 2–4 weeks

t½

n/a

Vial

n/a

Route

Subcutaneous (lipolysis)

Store

Room temp; use promptly

MIC blend with added B-complex vitamins. Ready-to-use solution — no reconstitution needed.

Dose

0.5–1 mL

Freq

Weekly

t½

n/a

Vial

n/a

Route

Intramuscular

Store

Refrigerate; solution

Methionine / inositol / choline lipotropic blend, often with B12, used in fat-loss clinic protocols. Supplied ready-to-use.

Dose

0.5–1 mL

Freq

1–2×/week

t½

n/a

Vial

n/a

Route

Intramuscular

Store

Refrigerate; solution

First-generation daily GLP-1 agonist. Shorter half-life than semaglutide, so titration is faster.

Dose

0.6–3 mg

Freq

Daily

t½

~13 h

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Human cathelicidin antimicrobial peptide studied for biofilm disruption and innate immunity.

Dose

100–500 mcg

Freq

Daily

t½

~1 h

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Collagen-signalling cosmetic peptide for wrinkle depth and skin firmness. Topical only.

Dose

Topical only

Freq

Daily

t½

n/a (topical)

Vial

10 mg

Route

Topical

Store

Refrigerate reconstituted; 30 days

Dual GLP-1/glucagon agonist in trials for weight and metabolic endpoints. Investigational.

Dose

1.5–9 mg

Freq

Weekly

t½

~6 days

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Melanocortin agonist. Skin tanning research. Start micro-dosed.

Dose

250–500 mcg

Freq

Daily titration

t½

~33 h

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Circadian hormone; injectable form used in sleep and antioxidant research.

Dose

0.5–5 mg

Freq

Before sleep

t½

~40 min

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

IGF-1Ec splice variant studied for satellite-cell activation after mechanical damage.

Dose

200–500 mcg

Freq

Post-workout

t½

~5–7 min

Vial

2 mg

Route

Intramuscular

Store

Refrigerate reconstituted; 28 days

Orally active ghrelin mimetic. Increases GH and IGF-1. Not injectable.

Dose

10–25 mg

Freq

Daily (oral)

t½

~24 h

Vial

n/a

Route

Oral

Store

Room temp; dry

Mitochondrial-derived peptide. Metabolic and exercise-mimetic research.

Dose

5–10 mg

Freq

2–3×/week

t½

~5 h

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Selective MC1R agonist for pigmentation with fewer systemic effects than Melanotan II.

Dose

500 mcg–1 mg

Freq

Daily loading

t½

~1 h

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Coenzyme precursor infused or injected for mitochondrial energy, NAD-salvage, and longevity research. Inject slowly — rapid delivery causes flushing.

Dose

50–500 mg

Freq

1–3×/week

t½

short

Vial

500 mg

Route

Subcutaneous / IV

Store

Refrigerate reconstituted; 30 days

Nonapeptide studied for social bonding, anxiety, and lactation.

Dose

10–40 IU / 100–400 mcg

Freq

As needed

t½

~3–5 min

Vial

5 mg

Route

Intranasal / subcutaneous

Store

Refrigerate reconstituted; 30 days

CNTF-derived peptide investigated for neurogenesis and BDNF signaling.

Dose

500 mcg–1 mg

Freq

Daily

t½

unknown

Vial

5 mg

Route

Subcutaneous / intranasal

Store

Refrigerate reconstituted; 30 days

Spadin analog (TREK-1 blocker) researched for rapid antidepressant action and synaptogenesis.

Dose

250–500 mcg

Freq

1–2×/day

t½

short

Vial

5 mg

Route

Intranasal

Store

Refrigerate reconstituted; 30 days

Pegylated MGF with greatly extended systemic half-life versus native MGF.

Dose

200–400 mcg

Freq

2–3×/week

t½

~48–72 h

Vial

2 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Short peptide bioregulator targeting brain tissue; cognition and neuroprotection research.

Dose

1–10 mg

Freq

Daily × 10–20 days

t½

short

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

p53-derived peptide studied preclinically for selective membrane disruption of cancer cells. Experimental only.

Dose

1–5 mg

Freq

Daily

t½

unknown

Vial

5 mg

Route

Subcutaneous / IV

Store

Refrigerate reconstituted; 28 days

Melanocortin agonist studied for sexual dysfunction.

Dose

0.75–2 mg

Freq

As needed

t½

~2 h

Vial

10 mg

Route

Subcutaneous / intranasal

Store

Refrigerate reconstituted; 30 days

Triple agonist (GIP/GLP-1/glucagon) in trials. Investigational.

Dose

1–12 mg

Freq

Weekly

t½

~6 days

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Supplier blend (20 mg Reta + 40 mg Tirz). Overlapping incretin agonism — high GI side-effect risk.

Dose

Per-component titration

Freq

Weekly

t½

~5–6 days

Vial

60 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Not a studied combination; dose conservatively.

Anxiolytic peptide analog of tuftsin. Nootropic research.

Dose

250–500 mcg

Freq

1–2×/day

t½

~30 min

Vial

5 mg

Route

Intranasal / subcutaneous

Store

Refrigerate reconstituted; 30 days

GLP-1 agonist. Weight management and glycemic control. Titrate slowly.

Dose

0.25–2.4 mg

Freq

Weekly

t½

~7 days

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 56 days

ACTH-derived heptapeptide studied for cognition and neuroprotection.

Dose

250–1000 mcg

Freq

1–2×/day

t½

~15 min

Vial

5 mg

Route

Intranasal / subcutaneous

Store

Refrigerate reconstituted; 30 days

GHRH 1-29 analog. Preserves natural pulsatile GH release.

Dose

100–500 mcg

Freq

Nightly

t½

~10 min

Vial

3 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

ERR agonist (exercise mimetic) studied preclinically for endurance and fat oxidation. Very limited human data.

Dose

250–500 mcg

Freq

Daily

t½

short (~hours)

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Octapeptide that inhibits SNAP-25 to soften expression lines. Topical cosmetic use — do not inject.

Dose

Topical only

Freq

Daily

t½

n/a (topical)

Vial

10 mg

Route

Topical

Store

Refrigerate reconstituted; 30 days

Mitochondria-targeted peptide investigated for cardiolipin stabilization.

Dose

3–5 mg

Freq

Daily

t½

~2 h

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Preservative-free diluent. No bacteriostat, so reconstituted vials must be used quickly or frozen.

Dose

1–5 mL per vial

Freq

Single use

t½

n/a

Vial

n/a

Route

Diluent

Store

Room temp; discard after use

Glucagon/GLP-1 dual agonist investigated for obesity and MASH. Investigational.

Dose

0.6–6 mg

Freq

Weekly

t½

~6 days

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Shorter active fragment of Thymosin Beta-4 researched for tissue repair with lower dosing.

Dose

200–500 mcg

Freq

Daily

t½

~2 h

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Actin-binding peptide fragment researched for tissue repair and inflammation.

Dose

2–5 mg

Freq

1–2×/week

t½

2–3 days

Vial

5 mg

Route

Subcutaneous / intramuscular

Store

Refrigerate reconstituted; 28 days

GHRH analog FDA-approved for HIV-associated lipodystrophy. Studied for visceral fat reduction.

Dose

1–2 mg

Freq

Daily

t½

~26 min

Vial

2 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Pre-mixed GHRH + GHRP blend (10 mg Tesamorelin / 5 mg Ipamorelin per vial) for visceral fat and GH support.

Dose

1 mg Tesa + 250 mcg Ipa

Freq

Nightly

t½

mixed

Vial

15 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 28 days

Blend vial: total mg is the sum of both compounds — enter total mg in the calculator, then read each component proportionally.

Thymic peptide extract used in Russian research for immune restoration in aging.

Dose

5–10 mg

Freq

Daily × 10 days

t½

short

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Immune modulating peptide. T-cell maturation research.

Dose

1.6 mg

Freq

2×/week

t½

~2 h

Vial

5 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Dual GIP/GLP-1 agonist. Titrate slowly to manage GI side effects.

Dose

2.5–15 mg

Freq

Weekly

t½

~5 days

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 42 days

Vascular endothelium bioregulator studied for blood-vessel wall integrity.

Dose

1–10 mg

Freq

Daily × 10–20 days

t½

short

Vial

10 mg

Route

Subcutaneous

Store

Refrigerate reconstituted; 30 days

Neuropeptide used in CIRS/mold-illness protocols for inflammatory and pulmonary markers.

Dose

50–100 mcg

Freq

1–4×/day

t½

~2 min

Vial

5 mg

Route

Intranasal

Store

Refrigerate reconstituted; 30 days